About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [579 citations: 1–100 of 561 articles]

Articles published in International Journal of Breast Cancer have been cited 579 times. The following is a list of the 561 articles that have cited the articles published in International Journal of Breast Cancer.

  • Roberta M. diFlorio-Alexander, Jonathan D. Marotti, Jesse S. Bond, Mary C. Schwab, Vincent A. Memoli, Wendy A. Wells, and Steven P. Poplack, “Breast MRI-Detected Cystic Apocrine Metaplasia: Imaging Features With Microvessel Analysis and Histologic Correlation,” American Journal of Roentgenology, vol. 204, no. 1, pp. 211–218, 2015. View at Publisher · View at Google Scholar
  • Geraldine Largey, Samantha Chakraborty, Tracey Tobias, Peter Briggs, and Danielle Mazza, “Audit of referral pathways in the diagnosis of lung cancer: a pilot study,” Australian Journal of Primary Health, vol. 21, no. 1, pp. 106, 2015. View at Publisher · View at Google Scholar
  • Aysegül Ilhan-Mutlu, Patrick Starlinger, Thomas Perkmann, Sebastian F Schoppmann, Matthias Preusser, and Peter Birner, “Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer,” Biomarkers in Medicine, vol. 9, no. 4, pp. 327–335, 2015. View at Publisher · View at Google Scholar
  • James Finlay, Cai M. Roberts, Gina Lowe, Joana Loeza, John J. Rossi, and Carlotta A. Glackin, “RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis,” BioMed Research International, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Diana Hatoum, and Eileen M. McGowan, “Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?,” BioMed Research International, vol. 2015, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Nalo Hamilton, Diana Márquez-Garbán, Vei Mah, Gowry Fernando, Yahya Elshimali, Hermes Garbán, David Elashoff, Jaydutt Vadgama, Lee Goodglick, and Richard Pietras, “ Biologic Roles of Estrogen Receptor- β and Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer ,” BioMed Research International, vol. 2015, pp. 1–15, 2015. View at Publisher · View at Google Scholar
  • Lauren L Bischel, David J Beebe, and Kyung E Sung, “Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure,” BMC Cancer, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Sofia Winslow, Karin Leandersson, Anders Edsjö, and Christer Larsson, “Prognostic stromal gene signatures in breast cancer,” Breast Cancer Research, vol. 17, no. 1, 2015. View at Publisher · View at Google Scholar
  • Jian Wen, Syn Yeo, Chenran Wang, Song Chen, Shaogang Sun, Michael A. Haas, Wei Tu, Feng Jin, and Jun-Lin Guan, “Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptos,” Breast Cancer Research And Treatment, vol. 149, no. 3, pp. 619–629, 2015. View at Publisher · View at Google Scholar
  • Zhen-Qiang Lian, Qi Wang, An-Qin Zhang, Jiang-Yu Zhang, Xiao-Rong Han, Hai-Yun Yu, and Si-Mei Xie, “A nomogram based on mammary ductoscopic indicators for evaluating the risk of breast cancer in intraductal neoplasms with nipple discharge,” Breast Cancer Research and Treatment, vol. 150, no. 2, pp. 373–380, 2015. View at Publisher · View at Google Scholar
  • J. R. Tichy, A. M. Deal, C. K. Anders, K. Reeder-Hayes, and L. A. Carey, “Race, response to chemotherapy, and outcome within clinical breast cancer subtypes,” Breast Cancer Research and Treatment, 2015. View at Publisher · View at Google Scholar
  • Elisa V. Bandera, Urmila Chandran, Chi-Chen Hong, Melissa A. Troester, Traci N. Bethea, Lucile L. Adams-Campbell, Christopher A. Haiman, Song-Yi Park, Andrew F. Olshan, Christine B. Ambrosone, Julie R. Palmer, and Lynn Rosenberg, “Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium,” Breast Cancer Research and Treatment, 2015. View at Publisher · View at Google Scholar
  • S Shen, Y Zhou, Y Xu, B Zhang, X Duan, R Huang, Q Sun, J Zhang, C Yu, H Jiang, S Li, S Han, J Ma, B Li, Y Shi, Z Shao, H Liao, J Jiang, and N Shen, “A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women,” British Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • A. Blythe Ryerson, Jacqueline Miller, and Christie R. Eheman, “Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program,” Cancer Causes & Control, 2015. View at Publisher · View at Google Scholar
  • Ali Roghanian, Ingrid Teige, Linda Mårtensson, Kerry L. Cox, Mathilda Kovacek, Anne Ljungars, Jenny Mattson, Annika Sundberg, Andrew T. Vaughan, Vallari Shah, Neil R. Smyth, Bhavwanti Sheth, H.T. Claude Chan, Zhan-Chun Li, Emily L. Williams, Giusi Manfredi, Robert J. Oldham, C. Ian Mockridge, Sonya A. James, Lekh N. Dahal, Khiyam Hussain, Björn Nilsson, J. Sjef Verbeek, Gunnar Juliusson, Markus Hansson, Mats Jerkeman, Peter W.M. Johnson, Andrew Davies, Stephen A. Beers, Martin J. Glennie, Björn Frendéus, and Mark S. Cragg, “Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo,” Cancer Cell, vol. 27, no. 4, pp. 473–488, 2015. View at Publisher · View at Google Scholar
  • Xi Gu, Yang Zhang, Long Chen, Jiao Guo, and Wen-Hai Zhang, “Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer,” Cancer Chemotherapy And Pharmacology, vol. 75, no. 2, pp. 301–308, 2015. View at Publisher · View at Google Scholar
  • Haojun Luo, Gang Tu, Manran Liu, and Zhimin Liu, “Cancer-associated fibroblasts: A multifaceted driver of breast cancer progression,” Cancer Letters, 2015. View at Publisher · View at Google Scholar
  • Ning-Bo Hao, Bo Tang, Guo-Zheng Wang, Rui Xie, Chang-Jiang Hu, Xia Xie, Su-Min Wang, Yu-Yun Wu, En Liu, Xia Xie, and Shi-Ming Yang, “Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis,” Cancer Letters, 2015. View at Publisher · View at Google Scholar
  • Guilherme Lellis Badke, Guilherme Brasileiro de Aguiar, João Miguel de Almeida Silva, Aline Lariessy Campos Paiva, Eduardo Urbano da Silva, and José Carlos Esteves Veiga, “Cerebral Metastasis from Breast Cancer in a Male Patient with HIV,” Case Reports in Neurological Medicine, vol. 2015, pp. 1–4, 2015. View at Publisher · View at Google Scholar
  • Ye-Seul Kim, Kyung-A Hwang, Sang-Hwan Hyun, Ki-Hoan Nam, Chang-Kyu Lee, and Kyung-Chul Choi, “Bisphenol A and nonylphenol have a potential to stimulate the migration of ovarian cancer cells by inducing epithelial-mesenchymal transition via an estrogen receptor dependent pathway,” Chemical Research in Toxicology, pp. 150217225153009, 2015. View at Publisher · View at Google Scholar
  • Eshvendar Reddy Kasala, Lakshmi Narendra Bodduluru, Chandana C. Barua, and Ranadeep Gogoi, “Chrysin and its emerging role in cancer drug resistance,” Chemico-Biological Interactions, 2015. View at Publisher · View at Google Scholar
  • Donna M. Sosnoski, Robert J. Norgard, Cassidy D. Grove, Shelby J. Foster, and Andrea M. Mastro, “Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment,” Clinical & Experimental Metastasis, 2015. View at Publisher · View at Google Scholar
  • Jesús Muñoz-Estrada, Gloria Benítez-King, Carlos Berlanga, and Isaura Meza, “Altered Subcellular Distribution of the 75-kDa DISC1 Isoform, cAMP Accumulation, and Decreased Neuronal Migration in Schizophrenia and Bipolar Disorder: Implications for Neurodevelopment,” CNS Neuroscience & Therapeutics, 2015. View at Publisher · View at Google Scholar
  • Maritha J. Kotze, Hilmar K. Lückhoff, Armand V. Peeters, Karin Baatjes, Mardelle Schoeman, Lize van der Merwe, Kathleen A. Grant, Leslie R. Fisher, Nicole van der Merwe, Jacobus Pretorius, David P. van Velden, Ettienne J. Myburgh, Fredrieka M. Pienaar, Susan J. van Rensburg, Yandiswa Y. Yako, Alison V. September, Kelebogile E. Moremi, Frans J. Cronje, Nicki Tiffin, Christianne S. H. Bouwens, Juanita Bezuidenhout, Justus P. Apffelstaedt, F. Stephen Hough, Rajiv T. Erasmus, and Johann W. Schneider, “Genomic medicine and risk prediction across the disease spectrum,” Critical Reviews in Clinical Laboratory Sciences, pp. 1–18, 2015. View at Publisher · View at Google Scholar
  • Antonio Gnoni, Nicola Silvestris, Antonella Licchetta, Daniele Santini, Mario Scartozzi, Roberto Ria, Salvatore Pisconti, Fausto Petrelli, Angelo Vacca, and Vito Lorusso, “Metronomic chemotherapy from rationale to clinical studies: A dream or reality?,” Critical Reviews in Oncology/Hematology, 2015. View at Publisher · View at Google Scholar
  • Michael C. Stauder, and Wendy A. Woodward, “Local-Regional Treatment of the Patient With Inflammatory Breast Cancer,” Current Breast Cancer Reports, 2015. View at Publisher · View at Google Scholar
  • Doris S. M. Chan, and Teresa Norat, “Obesity and Breast Cancer: Not Only a Risk Factor of the Disease,” Current Treatment Options in Oncology, vol. 16, no. 5, 2015. View at Publisher · View at Google Scholar
  • Jiewen Zhu, Hongyuan Chen, Xuning Emily Guo, Xiao-Long Qiu, Chun-Mei Hu, A. Richard Chamberlin, and Wen-Hwa Lee, “Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors,” European Journal of Medicinal Chemistry, vol. 96, pp. 196–208, 2015. View at Publisher · View at Google Scholar
  • Kelsey J. Weigel, Luqun Shen, Clayton L. Thomas, Daniel Alber, Lauren Drapalik, Zachary T. Schafer, and Shaun W. Lee, “Design and evaluation of a peptide-based immunotoxin for breast cancer therapeutics,” FEBS Open Bio, 2015. View at Publisher · View at Google Scholar
  • Fabrício C. Dias, Erick C. Castelli, Cristhianna V. A. Collares, Philippe Moreau, and Eduardo A. Donadi, “The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases,” Frontiers in Immunology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Fahimeh Falahi, Agustin Sgro, and Pilar Blancafort, “Epigenome Engineering in Cancer: Fairytale or a Realistic Path to the Clinic?,” Frontiers in Oncology, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Daniel M Trifiletti, Ryan Jones, Shayna L Showalter, Bruce B Libby, David R Brenin, Anneke Schroen, Monica M Morris, Kelli A Reardon, and Timothy N Showalter, “Techniques for intraoperative radiation therapy for early-stage breast carcinoma,” Future Oncology, vol. 11, no. 7, pp. 1047–1058, 2015. View at Publisher · View at Google Scholar
  • Nicola Huxley, Tracey Jones-Hughes, Helen Coelho, Tristan Snowsill, Chris Cooper, Yang Meng, Chris Hyde, and Rubén Mújica-Mota, “A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer,” Health Technology Assessment, vol. 19, no. 2, pp. 1–216, 2015. View at Publisher · View at Google Scholar
  • Sarah E Pinder, Emad A Rakha, Colin A Purdie, John M S Bartlett, Adele Francis, Robert C Stein, Alastair M Thompson, and Abeer M Shaaban, “Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches,” Histopathology, 2015. View at Publisher · View at Google Scholar
  • Anucha Apisarnthanarak, Nalini Singh, Aila Nica Bandong, and Gilbert Madriaga, “Triclosan-Coated Sutures Reduce the Risk of Surgical Site Infections: A Systematic Review and Meta-analysis,” Infection Control And Hospital Epidemiology, vol. 36, no. 2, pp. 169–179, 2015. View at Publisher · View at Google Scholar
  • Sonja Thaler, Gitta Thiede, Jan G. Hengstler, Arno Schad, Marcus Schmidt, and Jonathan P. Sleeman, “The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer,” International Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Patrice Penfornis, Krishna C. Vallabhaneni, Jason Whitt, and Radhika Pochampally, “Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment,” International Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Adam R. Wolfe, Rachel L. Atkinson, Jay P. Reddy, Bisrat G. Debeb, Richard Larson, Li Li, Hiroko Masuda, Takae Brewer, Bradley J. Atkinson, Abeena Brewster, Naoto T. Ueno, and Wendy A. Woodward, “High-Density and Very-Low-Density Lipoprotein Have Opposing Roles in Regulating Tumor-Initiating Cells and Sensitivity to Radiation in Inflammatory Breast Cancer,” International Journal of Radiation Oncology*Biology*Physics, vol. 91, no. 5, pp. 1072–1080, 2015. View at Publisher · View at Google Scholar
  • Manveen Bedi, and Gerald M. Devins, “Cultural considerations for South Asian women with breast cancer,” Journal of Cancer Survivorship, 2015. View at Publisher · View at Google Scholar
  • Jeong-Yeon Lee, Hee-Young Won, Ji-Hye Park, Hye-Yeon Kim, Hee-Joo Choi, Dong-Hui Shin, Ju-Hee Kang, Jong-Kyu Woo, Seung-Hyun Oh, Taekwon Son, Jin-Woo Choi, Sehwan Kim, Hyung-Yong Kim, Kijong Yi, Ki-Seok Jang, Young-Ha Oh, and Gu Kong, “MEL-18 loss mediates estrogen receptor–α downregulation and hormone independence,” Journal of Clinical Investigation, 2015. View at Publisher · View at Google Scholar
  • L. J. Tafe, H. B. Steinmetz, S. F. Allen, B. J. Dokus, and G. J. Tsongalis, “Rapid fluorescence in situ hybridisation (FISH) for HER2 (ERBB2) assessment in breast and gastro-oesophageal cancer,” Journal of Clinical Pathology, vol. 68, no. 4, pp. 306–308, 2015. View at Publisher · View at Google Scholar
  • Seema Patel, “Cereal bran fortified-functional foods for obesity and diabetes management: Triumphs, hurdles and possibilities,” Journal of Functional Foods, vol. 14, pp. 255–269, 2015. View at Publisher · View at Google Scholar
  • Walter Hans Meisen, Samuel Dubin, Steven T. Sizemore, Haritha Mathsyaraja, Katie Thies, Norman L. Lehman, Peter Boyer, Alena Cristina Jaime-Ramirez, J. Bradley Elder, Kimerly Powell, Arnab Chakravarti, Michael C. Ostrowski, and Balveen Kaur, “Changes in BAI1 and Nestin Expression Are Prognostic Indicators for Survival and Metastases in Breast Cancer and Provide Opportunities for Dual Target,” Molecular Cancer Therapeutics, vol. 14, no. 1, pp. 307–314, 2015. View at Publisher · View at Google Scholar
  • Zéna Wimana, G. Gebhart, T. Guiot, B. Vanderlinden, R. Morandini, G. Doumont, F. Sherer, G. Van Simaeys, S. Goldman, G. Ghanem, and P. Flamen, “Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [89Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model,” Molecular Imaging and Biology, 2015. View at Publisher · View at Google Scholar
  • Xiaohong R. Yang, J. Keith Killian, Sue Hammond, Laura S. Burke, Hunter Bennett, Yonghong Wang, Sean R. Davis, Louise C. Strong, Joseph Neglia, Marilyn Stovall, Rita E. Weathers, Leslie L. Robison, Smita Bhatia, Kiyohiko Mabuchi, Peter D. Inskip, and Paul Meltzer, “Characterization of Genomic Alterations in Radiation-Associated Breast Cancer among Childhood Cancer Survivors, Using Comparative Genomic Hybridizatio,” Plos One, vol. 10, no. 3, 2015. View at Publisher · View at Google Scholar
  • Kevin Dew, Maria Stubbe, Louise Signal, Jeannine Stairmand, Elizabeth Dennett, Jonathan Koea, Andrew Simpson, Diana Sarfati, Chris Cunningham, Lesley Batten, Lis Ellison-Loschmann, Josh Barton, and Maureen Holdaway, “Cancer Care Decision Making in Multidisciplinary Meetings,” Qualitative Health Research, vol. 25, no. 3, pp. 397–407, 2015. View at Publisher · View at Google Scholar
  • Manwen He, Shuai Guo, and Zhili Li, “ Dynamically in situ monitoring lipid changes in DHA-treated breast cells by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry ,” Rapid Communications in Mass Spectrometry, vol. 29, no. 10, pp. 987–990, 2015. View at Publisher · View at Google Scholar
  • Charles N. Prabhakar, Kwun M. Fong, Michael D. Peake, David C. Lam, and David J. Barnes, “The effectiveness of lung cancer MDT and the role of respiratory physicians,” Respirology, 2015. View at Publisher · View at Google Scholar
  • Karen Meneses, Rachel Benz, Andres Azuero, Rita Jablonski-Jaudon, and Patrick McNees, “Multimorbidity and Breast Cancer,” Seminars in Oncology Nursing, 2015. View at Publisher · View at Google Scholar
  • Margarita Smolina, and Erik Goormaghtigh, “Infrared imaging of MDA-MB-231 breast cancer cell line phenotypes in 2D and 3D cultures,” The Analyst, vol. 140, no. 7, pp. 2336–2343, 2015. View at Publisher · View at Google Scholar
  • Florian Ebner, Reyn van Ewijk, Achim Wöckel, Katharina Hancke, Lukas Schwentner, Visnja Fink, Rolf Kreienberg, Wolfgang Janni, and Maria Blettner, “Tumor biology in older breast cancer patients – What is the impact on survival stratified for guideline adherence? A retrospective multi-centre cohort study of 5378 patients,” The Breast, 2015. View at Publisher · View at Google Scholar
  • Md. Siddiqul Islam, Mohammad Safiqul Islam, Salma Parvin, Maizbah Uddin Ahmed, Muhammad Shahdaat Bin Sayeed, Mir Muhammad Nasir Uddin, Syed Md Akram Hussain, and Abul Hasnat, “Effect of GSTP1 and ABCC4 gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-5-fluorouracil-based chemotherapy in Bangladeshi breast cancer patients,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Gabriel Benton, Irina Arnaoutova, Jay George, Hynda K. Kleinman, and Jennifer Koblinski, “Matrigel: From discovery and ECM mimicry to assays and models for cancer research,” Advanced Drug Delivery Reviews, 2014. View at Publisher · View at Google Scholar
  • Robert Schmadeka, and Bryan E. Harmon, “Triple-Negative Breast Carcinoma Current and Emerging Concepts,” American Journal of Clinical Pathology, vol. 141, no. 4, pp. 462–477, 2014. View at Publisher · View at Google Scholar
  • Chi-Chih Kang, Jung-Ming G. Lin, Zhuchen Xu, Sanjay Kumar, and Amy E. Herr, “Single-Cell Western Blotting after Whole-Cell Imaging to Assess Cancer Chemotherapeutic Response,” Analytical Chemistry, pp. 141001090239005, 2014. View at Publisher · View at Google Scholar
  • Sophie Seronie-Vivien, “Circulating tumor cells: a new challenge for laboratory medicine,” Annales de Biologie Clinique, vol. 72, no. 2, pp. 153–177, 2014. View at Publisher · View at Google Scholar
  • A.S. Oger, J.M. Classe, O. Ingster, M.E. Morin-Meschin, B. Sauterey, G. Lorimier, R. Wernert, N. Paillocher, and P. Raro, “La chirurgie prophylactique chez les patientes mutées BRCA ou à haut risque : étude rétrospective de 61 patientes de l’ICO,” Annales de Chirurgie Plastique Esthétique, 2014. View at Publisher · View at Google Scholar
  • Yadong Yang, Wenyuan Zhang, Ying Li, Guojian Fang, and Keji Zhang, “Scalded Skin of Rat Treated by Using Fibrin Glue Combined with Allogeneic Bone Marrow Mesenchymal Stem Cells,” Annals of Dermatology, vol. 26, no. 3, pp. 289, 2014. View at Publisher · View at Google Scholar
  • D. S. M. Chan, A. R. Vieira, D. Aune, E. V. Bandera, D. C. Greenwood, A. McTiernan, D. Navarro Rosenblatt, I. Thune, R. Vieira, and T. Norat, “Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies,” Annals of Oncology, vol. 25, no. 10, pp. 1901–1914, 2014. View at Publisher · View at Google Scholar
  • John R. Dorris, and Suzanne Jones, “Everolimus in Breast Cancer: The Role of the Pharmacist,” Annals of Pharmacotherapy, vol. 48, no. 9, pp. 1194–1201, 2014. View at Publisher · View at Google Scholar
  • Mona P. Tan, Nadya Y. Sitoh, and Amanda S. Sim, “Breast conservation treatment for multifocal and multicentric breast cancers in women with small-volume breast tissue,” ANZ Journal of Surgery, 2014. View at Publisher · View at Google Scholar
  • Marjolein van Driel, and Johannes P.T.M. van Leeuwen, “Cancer and bone: A complex complex,” Archives of Biochemistry and Biophysics, 2014. View at Publisher · View at Google Scholar
  • Robin M. Elliott, Robert R. Shenk, Cheryl L. Thompson, and Hannah L. Gilmore, “Touch Preparations for the Intraoperative Evaluation of Sentinel Lymph Nodes After Neoadjuvant Therapy Have High False-Negative Rates in Patients With Breast Cancer,” Archives of Pathology & Laboratory Medicine, vol. 138, no. 6, pp. 814–818, 2014. View at Publisher · View at Google Scholar
  • Yi-Wen Chang, Mien-Chie Hung, and Jen-Liang Su, “The Anti-Tumor Activity of E1A and its Implications in Cancer Therapy,” Archivum Immunologiae et Therapiae Experimentalis, vol. 62, no. 3, pp. 195–204, 2014. View at Publisher · View at Google Scholar
  • Mitra Rahimzadeh, Ahmad Reza Baghestani, Mahmood Reza Gohari, and Mohamad Amin Pourhoseingholi, “Estimation of the Cure Rate in Iranian Breast Cancer Patients,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 12, pp. 4839–4842, 2014. View at Publisher · View at Google Scholar
  • Emna Fehri, Emna Ennaifer, Monia Ardhaoui, Kaouther Ouerhani, Thalja Laassili, Rahima Bel Haj Rhouma, Ikram Guizani, and Samir Boubaker, “Expression of Toll-like Receptor 9 Increases with Progression of Cervical Neoplasia in Tunisian Women - A Comparative Analysis of Condyloma, Cervical Intraepithelial Neoplasia and Invasive Carcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 15, pp. 6145–6150, 2014. View at Publisher · View at Google Scholar
  • Hassan Muhammad Yankuzo, Sharifah Tuan Sheriff Emilia, Rumaizi Shaari, and Nik Soriani Yaacob, “Correlation of Tumour Response with Starting Tumour Size and Dose of Tamoxifen in an N-Methyl-N-Nitrosourea (NMU)-Induced Rat Mammary Cancer Model,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 16, pp. 6721–6726, 2014. View at Publisher · View at Google Scholar
  • Zohreh Khakbazan, Ali Taghipour, Robab Latifnejad Roudsari, Eesa Mohammadi, and Ramesh Omranipour, “Delayed Presentation of Self-discovered Breast Cancer Symptoms in Iranian Women: A Qualitative Study,” Asian Pacific Journal Of Cancer Prevention, vol. 15, no. 21, pp. 9427–9432, 2014. View at Publisher · View at Google Scholar
  • Zahra Nikfarjam, Toktam Massoudi, Maryam Salehi, Mahta Salehi, and Fahimeh Khoshroo, “Demographic Survey of Four Thousand Patients with 10 Common Cancers in North Eastern Iran over the Past Three Decades,” Asian Pacific Journal Of Cancer Prevention, vol. 15, no. 23, pp. 10193–10198, 2014. View at Publisher · View at Google Scholar
  • Melva Louisa, Tjahjani Mirawati Soediro, and Frans Dhyanagiri Suyatna, “in vitro Modulation of P-glycoprotein, MRP-1 and BCRP Expression by Mangiferin in Doxorubicin-Treated MCF-7 Cells,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 4, pp. 1639–1642, 2014. View at Publisher · View at Google Scholar
  • Aswathy Sreedevi, Mariya Amin Quereshi, Beteena Kurian, and Leelamoni Kamalamma, “Screening for Breast Cancer in a Low Middle Income Country: Predictors in a Rural Area of Kerala, India,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 5, pp. 1919–1924, 2014. View at Publisher · View at Google Scholar
  • Ammad Ahmad Farooqi, Muhammad Zahid Qureshi, Ghazala Butt, and Aliye Aras, “Anthocyanins: Targeting of Signaling Networks in Cancer Cells,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 5, pp. 2379–2381, 2014. View at Publisher · View at Google Scholar
  • Khalid Hussain Sait, Nisrin Mohammad Anfinan, Basem Eldeek, Jawher Al-Ahmadi, Maha Al-Attas, Hesham Khalid Sait, Hussain Abdullah Basalamah, Nabeel Al-Ama, and Mohamed Eid El-Sayed, “Perception of Patients with Cancer towards Support Management Services and Use of Complementary Alternative Medicine - a Single Institution Hospital-Based Study in Saudi Arabia,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 6, pp. 2547–2554, 2014. View at Publisher · View at Google Scholar
  • Abu Bakar Hafeez Bhatti, Amina Iqbal Khan, Neelam Siddiqui, Nargis Muzaffar, Aamir Ali Syed, Mazhar Ali Shah, and Arif Jamshed, “Outcomes of Triple-Negative Versus Non-Triple-Negative Breast Cancers Managed with Breast-Conserving Therapy,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 6, pp. 2577–2581, 2014. View at Publisher · View at Google Scholar
  • Sifeng Tao, Haifei He, Qiang Chen, and Wenjie Yue, “GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Mafalda Videira, Rita Leones Reis, and Maria Alexandra Brito, “Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014. View at Publisher · View at Google Scholar
  • Vesna Brglez, Gérard Lambeau, and Toni Petan, “Secreted phospholipases A2 in cancer: Diverse mechanisms of action,” Biochimie, 2014. View at Publisher · View at Google Scholar
  • Ruichuan Chen, Jasper H. N. Yik, Qiao Jing Lew, and Sheng-Hao Chao, “Brd4 and HEXIM1: Multiple Roles in P-TEFb Regulation and Cancer,” BioMed Research International, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Lea A. Koch, Volker Schmitz, Christian P. Strassburg, and Esther Raskopf, “Plasmid Transfer of Plasminogen K1-5 Reduces Subcutaneous Hepatoma Growth by Affecting Inflammatory Factors,” BioMed Research International, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Roba Talaat, Waheba El-Sayed, Hussein Agwa, Amira Gamal-Eldeen, Shaden Moawia, and Magdy Zahran, “Novel thalidomide analogs: Anti-angiogenic and apoptotic effects on Hep-G2 and MCF-7 cancer cell lines,” Biomedicine & Aging Pathology, vol. 4, no. 3, pp. 179–189, 2014. View at Publisher · View at Google Scholar
  • Hua Shen, Jinyuan Liu, Rong Wang, Xu Qian, Ruitong Xu, Tongpeng Xu, Qi Li, Lin Wang, Zhumei Shi, Jitai Zheng, Qiudan Chen, and Yongqian Shu, “Fulvestrant increases gefitinib sensitivity in non-small cell lung cancer cells by upregulating let-7c expression,” Biomedicine & Pharmacotherapy, vol. 68, no. 3, pp. 307–313, 2014. View at Publisher · View at Google Scholar
  • Yiyi Liu, Quanquan Gu, Jack P. Hou, Jiawei Han, and Jian Ma, “A network-assisted co-clustering algorithm to discover cancer subtypes based on gene expression,” Bmc Bioinformatics, vol. 15, 2014. View at Publisher · View at Google Scholar
  • Catarina Rodrigues dos Santos, Isabel Fonseca, Sergio Dias, and J. C. Mendes de Almeida, “Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Ashley M. Brinkman, Jiacai Wu, Karen Ersland, and Wei Xu, “Estrogen receptor alpha and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Charlotte Levin Tykjr Jorgensen, Christina Bjerre, Bent Ejlertsen, Karsten D. Bjerre, Eva Balslev, Annette Bartels, Nils Brunner, and Dorte L. Nielsen, “TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Mohammad Sorowar Hossain, Mohd S. Iqbal, Mohiuddin Ahmed Khan, Mohammad Golam Rabbani, Hazera Khatun, Sirajam Munira, M. Morshed Zaman Miah, Amin Lutful Kabir, Naima Islam, Tashmim Farhana Dipta, Farzana Rahman, Abdul Mottalib, Salma Afrose, Tasneem Ara, Akhil Ranjan Biswas, Mizanur Rahman, A. K. M. Mustafa Abedin, Mahbubur Rahman, A. B. M. Yunus, Louis W. Niessen, and Tanvira Afroze Sultana, “Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Yuriy Shapovalov, Martha Zettel, Sara C. Spielman, Stacy A. Amico-Ruvio, Emily A. Kelly, Grayson O. Sipe, Ian M. Dickerson, Ania K. Majewska, and Edward B. Brown, “Fluoxetine modulates breast cancer metastasis to the brain in a murine model,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Jordan M. Reese, Vera J. Suman, Malayannan Subramaniam, Xianglin Wu, Vivian Negron, Anne Gingery, Kevin S. Pitel, Sejal S. Shah, Heather E. Cunliffe, Ann E. McCullough, Barbara A. Pockaj, Fergus J. Couch, Janet E. Olson, Carol Reynolds, Wilma L. Lingle, Thomas C. Spelsberg, Matthew P. Goetz, James N. Ingle, and John R. Hawse, “ER beta 1: characterization, prognosis, and evaluation of treatment strategies in ER alpha-positive and -negative breast cancer,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Silvia von der Heyde, Carolin Fromm-Dornieden, Gabriela Salinas-Riester, Tim Beissbarth, and Bernhard G. Baumgartner, “Dynamics of mRNA and polysomal abundance in early 3T3-L1 adipogenesis,” Bmc Genomics, vol. 15, 2014. View at Publisher · View at Google Scholar
  • Yang Liu, and Zhenjun Hu, “Identification of collaborative driver pathways in breast cancer,” Bmc Genomics, vol. 15, 2014. View at Publisher · View at Google Scholar
  • Meaghann S. Weaver, Christina L. Heminger, and Catherine G. Lam, “Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomes,” Bmc Public Health, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Fakher Rahim, Saeideh Hajizamani, Esmaeil Mortaz, Ahmad Ahmadzadeh, Mohammad Shahjahani, Saeid Shahrabi, and Najmaldin Saki, “Molecular Regulation of Bone Marrow Metastasis in Prostate and Breast Cancer,” Bone Marrow Research, vol. 2014, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  • Peter JK Kuppen, and Esther M de Kruijf, “Considerations on the prognostic and predictive significance of HLA-G in breast cancer,” Breast Cancer Management, vol. 3, no. 4, pp. 307–309, 2014. View at Publisher · View at Google Scholar
  • Heidi S. Wirtz, Denise M. Boudreau, Julie R. Gralow, William E. Barlow, Shelly Gray, Erin J. A. Bowles, and Diana S. M. Buist, “Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Candyce H. Kroenke, Carol Sweeney, Marilyn L. Kwan, Charles P. Quesenberry, Erin K. Weltzien, Laurel A. Habel, Adrienne Castillo, Phillip S. Bernard, Rachel E. Factor, Lawrence H. Kushi, and Bette J. Caan, “Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • C. Arce-Salinas, J. L. Aguilar-Ponce, C. Villarreal-Garza, F. U. Lara-Medina, D. Olvera-Caraza, A. Alvarado Miranda, D. Flores-Díaz, and A. Mohar, “Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Susann E. Schetter, Terryl J. Hartman, Jason Liao, John P. Richie, Bogdan Prokopczyk, Cindy DuBrock, Carina Signori, Christopher Hamilton, Laurence M. Demers, Karam El-Bayoumy, and Andrea Manni, “Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Cynthia Villarreal-Garza, Daniel Khalaf, Nathaniel Bouganim, Mark Clemons, Omar Peña-Curiel, Berenice Baez-Revueltas, Alexander Kiss, Farah Kassam, Katherine Enright, Sunil Verma, Kathleen Pritchard, Jeff Myers, and Rebecca Dent, “Platinum-based chemotherapy in triple-negative advanced breast cancer,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Martin P. Nilsson, Linda Hartman, Ulf Kristoffersson, Oskar T. Johannsson, Åke Borg, Karin Henriksson, Elsa Lanke, Håkan Olsson, and Niklas Loman, “High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Dagmar Hauner, and Hans Hauner, “Metabolic Syndrome and Breast Cancer: Is There a Link?,” Breast Care, vol. 9, no. 4, pp. 277–281, 2014. View at Publisher · View at Google Scholar